tradingkey.logo

Capricor Therapeutics launches equity offering following stock surge

ReutersDec 4, 2025 9:28 PM

Capricor Therapeutics' CAPR.O shares up 3.2% at $26.20 i n extended trading as it looks to raise equity

San Diego, California-based biotech firm commences stock offering without disclosing deal size

CAPR shares surged 371% to an 8-year high on Weds after co said its experimental cell therapy, deramiocel, slowed the progression of Duchenne muscular dystrophy (DMD) in a late-stage trial

Shares closed down 15.2% at $25.40 on Thurs

With ~45.7 mln shares outstanding, CAPR has ~$1.2 bln market cap

Co intends to use net offering proceeds for continued development and manufacturing of its product candidates, among other purposes

Piper Sandler and Oppenheimer are joint bookrunners

All 10 analysts are bullish on CAPR; median PT of $44 up from $21.50 a month ago, per LSEG

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI